Literature DB >> 35557039

Can SpRY recognize any PAM in human cells?

Jinbin Ye1, Haitao Xi1, Yilu Chen1, Qishu Chen1, Xiaosheng Lu1, Jineng Lv2, Yamin Chen2, Feng Gu3, Junzhao Zhao4.   

Abstract

The application of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) can be limited due to a lack of compatible protospacer adjacent motif (PAM) sequences in the DNA regions of interest. Recently, SpRY, a variant of Streptococcus pyogenes Cas9 (SpCas9), was reported, which nearly completely fulfils the PAM requirement. Meanwhile, PAMs for SpRY have not been well addressed. In our previous study, we developed the PAM Definition by Observable Sequence Excision (PAM-DOSE) and green fluorescent protein (GFP)‍-reporter systems to study PAMs in human cells. Herein, we endeavored to identify the PAMs of SpRY with these two methods. The results indicated that 5'-NRN-3', 5'-NTA-3', and 5'-NCK-3' could be considered as canonical PAMs. 5'-NCA-3' and 5'-NTK-3' may serve as non-priority PAMs. At the same time, PAM of 5'-NYC-3' is not recommended for human cells. These findings provide further insights into the application of SpRY for human genome editing.

Entities:  

Keywords:  CRISPR/Cas; Protospacer adjacent motif (PAM); Recognize; SpRY

Mesh:

Substances:

Year:  2022        PMID: 35557039      PMCID: PMC9110322          DOI: 10.1631/jzus.B2100710

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


Can SpRY recognize any PAM in human cells?
  25 in total

1.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

2.  Analyzing CRISPR genome-editing experiments with CRISPResso.

Authors:  Luca Pinello; Matthew C Canver; Megan D Hoban; Stuart H Orkin; Donald B Kohn; Daniel E Bauer; Guo-Cheng Yuan
Journal:  Nat Biotechnol       Date:  2016-07-12       Impact factor: 54.908

3.  Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.

Authors:  Seiichi Hirano; Hiroshi Nishimasu; Ryuichiro Ishitani; Osamu Nureki
Journal:  Mol Cell       Date:  2016-03-17       Impact factor: 17.970

4.  Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNAGln-processing system in human cells.

Authors:  Xiubin He; Yufei Wang; Fayu Yang; Bang Wang; Haihua Xie; Lingkai Gu; Tianyuan Zhao; Xiexie Liu; Dingbo Zhang; Qianwen Ren; Xiaoyu Liu; Yong Liu; Caixia Gao; Feng Gu
Journal:  J Biol Chem       Date:  2019-04-22       Impact factor: 5.157

5.  DNA targeting specificity of RNA-guided Cas9 nucleases.

Authors:  Patrick D Hsu; David A Scott; Joshua A Weinstein; F Ann Ran; Silvana Konermann; Vineeta Agarwala; Yinqing Li; Eli J Fine; Xuebing Wu; Ophir Shalem; Thomas J Cradick; Luciano A Marraffini; Gang Bao; Feng Zhang
Journal:  Nat Biotechnol       Date:  2013-07-21       Impact factor: 54.908

6.  Short motif sequences determine the targets of the prokaryotic CRISPR defence system.

Authors:  F J M Mojica; C Díez-Villaseñor; J García-Martínez; C Almendros
Journal:  Microbiology       Date:  2009-03       Impact factor: 2.777

7.  CRISPR/Cas9-loxP-Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation Tool.

Authors:  Fayu Yang; Changbao Liu; Ding Chen; Mengjun Tu; Haihua Xie; Huihui Sun; Xianglian Ge; Lianchao Tang; Jin Li; Jiayong Zheng; Zongming Song; Jia Qu; Feng Gu
Journal:  Mol Ther Nucleic Acids       Date:  2017-04-25

8.  Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cells.

Authors:  Lianchao Tang; Fayu Yang; Xiaoxue He; Haihua Xie; Xiaoyu Liu; Junhao Fu; Haitao Xi; Xiaosheng Lu; Changbao Liu; Zongming Song; Jia Qu; Junzhao Zhao; Feng Gu
Journal:  Cell Regen (Lond)       Date:  2019-10-28

9.  SpRY greatly expands the genome editing scope in rice with highly flexible PAM recognition.

Authors:  Ziyan Xu; Yongjie Kuang; Bin Ren; Daqi Yan; Fang Yan; Carl Spetz; Wenxian Sun; Guirong Wang; Xueping Zhou; Huanbin Zhou
Journal:  Genome Biol       Date:  2021-01-04       Impact factor: 13.583

10.  In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.

Authors:  Weiwei Zhang; Jianhang Yin; Zhengrong Zhang-Ding; Changchang Xin; Mengzhu Liu; Yuhong Wang; Chen Ai; Jiazhi Hu
Journal:  Nucleic Acids Res       Date:  2021-06-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.